Clinical Trial Update: Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan-eluting LC bead (DEBIRI-M1) for liver metastases from colorectal cancer completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)

Snippet

Sponsor: Yale University | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-22